Box score
Ovala, Inc.
Reported $3.3M sold in a new Form D filed March 31, 2026 (Pittsburgh, Pennsylvania).
- Biggest raise
- $3.3M filed Mar 31, 2026
- League
- Bio & Health Biotechnology
- Based in
- Pittsburgh, Pennsylvania
- Season rank
- #423 of 1,121 in the Bio & Health League; #3611 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-03-31 | New notice | $3.3M | $13M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1936997.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Aortic Solutions, Inc. rookie | Bio & Health | $3.7M |
| 2 | Glycotest Inc. rookie | Bio & Health | $3.2M |
| 3 | Cantai Therapeutics, Inc. | Bio & Health | $3M |
| 4 | NexEos Diagnostics, Inc. | Bio & Health | $3M |
| 5 | Praeventix, Inc. | Bio & Health | $3M |
| 6 | Xenagos Bio, Inc. rookie | Bio & Health | $2.5M |